ClinicalThought

Share

Program Content

Activities

  • ADCs Targeting CEACAM5 in NSCLC
    The Potential of Antibody‒Drug Conjugates Targeting CEACAM5 in NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 30, 2023

Faculty

cover img faculity

David Planchard, MD, PhD

Head of Thoracic Cancer Group
Department of Medical Oncology
Gustave Roussy
Villejuif, France

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi